Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies — Stella

Home/Monoclonal Gammopathy of Undetermined Significance/

View on ClinicalTrials.gov

Recruiting

Back to Monoclonal Gammopathy of Undetermined Significance trials

Trial locations(1 site)

United States

M D Anderson Cancer Center, Houston, Texas

Key details

Sponsor

M.D. Anderson Cancer Center

Collaborators

National Cancer Institute (NCI)

Enrollment target

~400 participants

Started

June 2016

Primary completion

February 2027

Age range

18 Years and older

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.